# US 2024/0197820 A1 · Bacteriocin for new application

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0197820 A1
- Document ID: US20240197820A1
- Status: Published application
- Kind: A1
- Application number: 18/566,900
- Filed: 2022-05-30
- Published: 2024-06-20
- Earliest claimed: 2021-06-02
- Assignees: Syngulon SA
- Applicants: Syngulon S.A.
- Inventors: Philippe Gabant; Félix Jaumaux
- Web page: https://patentgrep.com/patent/US20240197820A1

## CPC

- A61K 38/164: {from bacteria}
- A01N 37/46: N-acyl derivatives
- A01N 63/22: Bacillus
- A01P 1/00: Disinfectants; Antimicrobial compounds or mixtures thereof
- A61K 8/64: Proteins; Peptides; Derivatives or degradation products thereof
- A61K 8/99: from microorganisms other than algae or fungi, e.g. protozoa or bacteria
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61P 17/00: Drugs for dermatological disorders
- A61P 31/04: Antibacterial agents
- A61Q 17/005: {Antimicrobial preparations}
- C07K 14/32: from Bacillus (G)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01P: BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

Described herein are bacteriocin peptides, peptidomimetics, compositions, pharmaceutical compositions, and cosmetic compositions comprising same. Aspects and embodiments described herein may be used in medical treatment, disinfection of surfaces and cosmetics.

## Claims

### Claim 1

A bacteriocin peptide or peptidomimetic, wherein said peptide or peptidomimetic comprises, essentially consists of, or consists of a peptide or peptidomimetic represented by the amino acid sequence of SEQ ID NO: 2, or by an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 95%, or 99% identity or similarity with SED ID NO: 2, for use in the treatment, prevention and/or delaying of an infection on a subject, preferably a human subject, wherein the infection is:
a. a skin infection and/or
b. caused by Staphylococcus aureus.

### Claim 2 (depends on 1)

A bacteriocin peptide or peptidomimetic for use according to claim 1, wherein the skin infection is caused by a bacterium, preferably a Gram-positive bacterium.

### Claim 3 (depends on 2)

A bacteriocin peptide or peptidomimetic for use according to claim 2, wherein the bacterium is Staphylococcus aureus.

### Claim 4 (depends on 1, 3)

A bacteriocin peptide or peptidomimetic for use according to claim 1 or 3, wherein the Staphylococcus aureus is methicillin-resistant.

### Claim 5 (depends on 1, 2, 3, 4)

A bacteriocin peptide or peptidomimetic for use according to any one of claims 1-4, wherein said use does not inhibit at least one of the microbial cells normally present on the subject's skin, preferably Staphylococcus epidermidis.

### Claim 6 (depends on 1, 2, 3, 4, 5)

A composition comprising a bacteriocin peptide or peptidomimetic as defined in any one of claims 1-5.

### Claim 7 (depends on 6)

A composition according to claim 6, wherein said composition is a pharmaceutical composition optionally further comprising one or more antimicrobial compounds and/or pharmaceutically acceptable ingredients.

### Claim 8 (depends on 1, 2, 3, 4, 5, 7)

A pharmaceutical composition according to claim 7 for use according to any one of claims 1-5.

### Claim 9 (depends on 1, 2, 3, 4, 5, 8)

A bacteriocin peptide or peptidomimetic for use according to any one of claims 1-5, or a pharmaceutical composition for use according to claim 8, wherein said peptide, peptidomimetic, or composition is administered topically or transdermally, preferably on a wound, lesion, or abscess.

### Claim 10 (depends on 6)

A composition according to claim 6, wherein said composition is a cosmetic composition optionally further comprising one or more antimicrobial compounds and/or cosmetically acceptable ingredients.

### Claim 11 (depends on 1, 2, 3, 4, 5, 10)

A cosmetic method of providing an improvement of skin hygiene comprising applying to the skin a bacteriocin peptide or peptidomimetic as defined in any one of claims 1-5, or a cosmetic composition as defined in claim 10.

### Claim 12 (depends on 1, 4, 6)

A composition according to claim 6, wherein said composition comprises a bacteriocin peptide or peptidomimetic as defined in claim 1 or 4, wherein said composition is suitable for disinfecting a surface contaminated with Staphylococcus aureus, optionally further comprising one or more antimicrobial compounds and/or a solvent.

### Claim 13 (depends on 1, 4, 12)

An ex-vivo method of disinfecting a surface comprising contacting said surface with a bacteriocin peptide or peptidomimetic as defined in claim 1 or 4, or with a composition as defined in claim 12.

### Claim 14

A bacteriocin peptide or peptidomimetic, wherein said peptide or peptidomimetic comprises, essentially consists of, or consists of a peptide or peptidomimetic represented by the amino acid sequence of any one of SEQ ID NOs: 7, 8, 15, 18, 19, 22, 24, 34, 37, 40, 42, 44, 47, 48, or 51.
